Stroke prevention by traditional Chinese medicine? A genetic algorithm, support vector machine and molecular dynamics approach

被引:55
作者
Chen, Kuan-Chung [1 ]
Chen, Calvin Yu-Chian [1 ,2 ,3 ,4 ]
机构
[1] China Med Univ, Sch Chinese Med, Lab Computat & Syst Biol, Taichung 40402, Taiwan
[2] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA
[3] Asia Univ, Dept Bioinformat, Taichung 41354, Taiwan
[4] MIT, Dept Computat & Syst Biol, Cambridge, MA 02139 USA
关键词
PHOSPHODIESTERASE 4D GENE; ISCHEMIC-STROKE; DRUG DESIGN; PDE4D GENE; ASSOCIATION; INHIBITORS; POPULATION; MODEL; MINIMIZATION; AGGREGATION;
D O I
10.1039/c0sm01548b
中图分类号
O64 [物理化学(理论化学)、化学物理学];
学科分类号
070304 ; 081704 ;
摘要
Phosphodiesterase 4D (PDE4D) has been identified be a promising target which associate with stroke, which is one of the top 3 leading of death and main leading cause of adult disability in US. In this study, we applied virtual screening on the world's largest traditional Chinese medicine (TCM) database (http://tcm.cmu.edu.tw;(1) C. Y. C. Chen, PLoS One, 2011, 6, e15939) for natural compounds that inhibit PDE4D functions. Molecular docking and dynamics simulation were employed to investigate the protein-ligand interactions of compounds with top two dock scores. During the simulation, the divalent metal cations in PDE4D formed stable hydrogen bonds and electrostatic interactions between ligand and binding site residues. Furthermore, the two top TCM candidates, 2-O-caffeoyl tartaric acid and mumefural, formed additional steady hydrogen bond with binding site residue and active site residue respectively. The additional hydrogen bonds further stabilize protein-ligand interaction at the PDE4D binding site. To predict the bioactivity of the top TCM candidates, we built two prediction models using multiple linear regression (MLR) and support vector machine (SVM). The predicted pIC50 values suggest that 2-O-caffeoyl tartaric acid and mumefural are potential PDE4D inhibitors.
引用
收藏
页码:4001 / 4008
页数:8
相关论文
共 46 条
  • [1] [Anonymous], 2003, NONLINEAR PROGRAMMIN
  • [2] The discovery and synthesis of highly potent subtype selective phosphodiesterase 4D inhibitors
    Aspiotis, Renee
    Deschenes, Denis
    Dube, Daniel
    Girard, Yves
    Huang, Zheng
    Laliberte, France
    Liu, Susana
    Papp, Robert
    Nicholson, Donald W.
    Young, Robert N.
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (18) : 5502 - 5505
  • [3] Community participation following cerebrovascular accident: Impact of the buffering model of social support
    Beckley, MN
    [J]. AMERICAN JOURNAL OF OCCUPATIONAL THERAPY, 2006, 60 (02) : 129 - 135
  • [4] Phosphodiesterase 4D gene, ischemic stroke, and asymptomatic carotid atherosclerosis
    Bevan, S
    Porteous, L
    Sitzer, M
    Markus, HS
    [J]. STROKE, 2005, 36 (05) : 949 - 953
  • [5] CHARMM - A PROGRAM FOR MACROMOLECULAR ENERGY, MINIMIZATION, AND DYNAMICS CALCULATIONS
    BROOKS, BR
    BRUCCOLERI, RE
    OLAFSON, BD
    STATES, DJ
    SWAMINATHAN, S
    KARPLUS, M
    [J]. JOURNAL OF COMPUTATIONAL CHEMISTRY, 1983, 4 (02) : 187 - 217
  • [6] Association of phosphodiesterase 4D polymorphisms with ischemic stroke in a US population stratified by hypertension status
    Brophy, VH
    Ro, SK
    Rhees, BK
    Lui, LY
    Lee, JM
    Umblas, N
    Bentley, LG
    Li, J
    Cheng, S
    Browner, WS
    Erlich, HA
    [J]. STROKE, 2006, 37 (06) : 1385 - 1390
  • [7] Design of phosphodiesterase 4D (PDE4D) allosteric modulators for enhancing cognition with improved safety
    Burgin, Alex B.
    Magnusson, Olafur T.
    Singh, Jasbir
    Witte, Pam
    Staker, Bart L.
    Bjornsson, Jon M.
    Thorsteinsdottir, Margret
    Hrafnsdottir, Sigrun
    Hagen, Timothy
    Kiselyov, Alex S.
    Stewart, Lance J.
    Gurney, Mark E.
    [J]. NATURE BIOTECHNOLOGY, 2010, 28 (01) : 63 - U93
  • [8] A family of phosphodiesterase inhibitors discovered by cocrystallography and scaffold-based drug design
    Card, GL
    Blasdel, L
    England, BP
    Zhang, C
    Suzuki, Y
    Gillette, S
    Fong, D
    Ibrahim, PN
    Artis, DR
    Bollag, G
    Milburn, MV
    Kim, SH
    Schlessinger, J
    Zhang, KYJ
    [J]. NATURE BIOTECHNOLOGY, 2005, 23 (02) : 201 - 207
  • [9] Quiquelignan A-H, eight new lignoids from the rattan palm Calamus quiquesetinervius and their antiradical, anti-inflammatory and antiplatelet aggregation activities
    Chang, Chao-Lin
    Zhang, Li-Jie
    Chen, Ru-Yin
    Wu, Chin-Chung
    Huang, Hui-Chi
    Roy, Michael C.
    Huang, Jhih-Ping
    Wu, Yang-Chang
    Kuo, Yao-Haur
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2010, 18 (02) : 518 - 525
  • [10] Key Features for Designing Phosphodiesterase-5 Inhibitors
    Chang, Tung-Ti
    Huang, Hung-Jin
    Lee, Kuei-Jen
    Yu, Hsin Wei
    Chen, Hsin-Yi
    Tsai, Fuu-Jen
    Sun, Mao-Feng
    Chen, Calvin Yu-Chian
    [J]. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2010, 28 (03) : 309 - 321